questionsmedicales.fr
Maladies du système nerveux
Maladies du système nerveux central
Encéphalopathies
Épilepsie
Épilepsies partielles
Épilepsie partielle complexe
Épilepsie partielle complexe : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Épilepsie
Électroencéphalographie
IRM
Électroencéphalographie
Antécédents médicaux
Épilepsie
Symptômes
5
Symptômes
Crises épileptiques
Comportements automatisés
Épilepsie
Prévention
5
Éducation
Premiers secours
Activités physiques
Sécurité
Gestion du stress
Méditation
Traitements
5
Anticonvulsivants
Carbamazépine
Thérapies comportementales
Stimulation cérébrale
Complications
5
Complications
Psychologiques
Prise en charge
Multidisciplinaire
Facteurs de risque
5
Facteurs de risque
Traumatismes crâniens
Maladies neurologiques
Sclérose en plaques
Facteurs environnementaux
Toxines
Stress
Crises épileptiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Épilepsie partielle complexe : Questions médicales les plus fréquentes",
"headline": "Épilepsie partielle complexe : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Épilepsie partielle complexe : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-30",
"dateModified": "2025-04-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Épilepsie partielle complexe"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Épilepsies partielles",
"url": "https://questionsmedicales.fr/mesh/D004828",
"about": {
"@type": "MedicalCondition",
"name": "Épilepsies partielles",
"code": {
"@type": "MedicalCode",
"code": "D004828",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.228.140.490.360"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Épilepsie partielle complexe",
"alternateName": "Epilepsy, Complex Partial",
"code": {
"@type": "MedicalCode",
"code": "D017029",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Xiao-Rong Liu",
"url": "https://questionsmedicales.fr/author/Xiao-Rong%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China."
}
},
{
"@type": "Person",
"name": "Yong-Hong Yi",
"url": "https://questionsmedicales.fr/author/Yong-Hong%20Yi",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China."
}
},
{
"@type": "Person",
"name": "Jie Wang",
"url": "https://questionsmedicales.fr/author/Jie%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China."
}
},
{
"@type": "Person",
"name": "Wei-Ping Liao",
"url": "https://questionsmedicales.fr/author/Wei-Ping%20Liao",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Photoswitchable Probes of Oxytocin and Vasopressin.",
"datePublished": "2023-10-19",
"url": "https://questionsmedicales.fr/article/37857356",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.jmedchem.3c01415"
}
},
{
"@type": "ScholarlyArticle",
"name": "Modulation of social behavior by distinct vasopressin sources.",
"datePublished": "2023-02-13",
"url": "https://questionsmedicales.fr/article/36860367",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2023.1127792"
}
},
{
"@type": "ScholarlyArticle",
"name": "Vasopressin Response and Clinical Trajectory in Septic Shock Patients.",
"datePublished": "2022-09-04",
"url": "https://questionsmedicales.fr/article/36062611",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/08850666221118282"
}
},
{
"@type": "ScholarlyArticle",
"name": "Norepinephrine and Vasopressin in Hemorrhagic Shock: A Focus on Renal Hemodynamics.",
"datePublished": "2023-02-17",
"url": "https://questionsmedicales.fr/article/36835514",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24044103"
}
},
{
"@type": "ScholarlyArticle",
"name": "Meta-Analysis of Efficacy of Vasopressin During Cardiopulmonary Resuscitation.",
"datePublished": "2022-08-05",
"url": "https://questionsmedicales.fr/article/35934565",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.amjcard.2022.06.042"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009422"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies du système nerveux central",
"item": "https://questionsmedicales.fr/mesh/D002493"
},
{
"@type": "ListItem",
"position": 4,
"name": "Encéphalopathies",
"item": "https://questionsmedicales.fr/mesh/D001927"
},
{
"@type": "ListItem",
"position": 5,
"name": "Épilepsie",
"item": "https://questionsmedicales.fr/mesh/D004827"
},
{
"@type": "ListItem",
"position": 6,
"name": "Épilepsies partielles",
"item": "https://questionsmedicales.fr/mesh/D004828"
},
{
"@type": "ListItem",
"position": 7,
"name": "Épilepsie partielle complexe",
"item": "https://questionsmedicales.fr/mesh/D017029"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Épilepsie partielle complexe - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Épilepsie partielle complexe",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Épilepsie partielle complexe",
"description": "Comment diagnostique-t-on l'épilepsie partielle complexe ?\nQuels tests sont utilisés pour confirmer le diagnostic ?\nLes symptômes peuvent-ils varier d'un patient à l'autre ?\nQuel rôle joue l'historique médical dans le diagnostic ?\nPeut-on diagnostiquer l'épilepsie partielle complexe chez les enfants ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Vasopressins#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Épilepsie partielle complexe",
"description": "Quels sont les symptômes typiques des crises ?\nLes crises peuvent-elles affecter la mémoire ?\nComment se manifestent les comportements automatisés ?\nLes crises peuvent-elles être précédées d'aura ?\nLes symptômes peuvent-ils persister après la crise ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Vasopressins#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Épilepsie partielle complexe",
"description": "Peut-on prévenir les crises d'épilepsie partielle complexe ?\nQuels sont les déclencheurs courants des crises ?\nL'éducation des proches est-elle importante ?\nLes activités physiques sont-elles sûres ?\nComment gérer le stress pour prévenir les crises ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Vasopressins#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Épilepsie partielle complexe",
"description": "Quels médicaments sont couramment prescrits ?\nLa chirurgie est-elle une option de traitement ?\nQuelles sont les alternatives aux médicaments ?\nComment évaluer l'efficacité du traitement ?\nLes changements de mode de vie peuvent-ils aider ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Vasopressins#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Épilepsie partielle complexe",
"description": "Quelles sont les complications possibles de l'épilepsie ?\nL'épilepsie peut-elle affecter la vie sociale ?\nY a-t-il un risque accru de dépression ?\nLes crises peuvent-elles entraîner des blessures graves ?\nComment les complications peuvent-elles être gérées ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Vasopressins#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Épilepsie partielle complexe",
"description": "Quels sont les facteurs de risque de l'épilepsie partielle complexe ?\nL'âge influence-t-il le risque d'épilepsie ?\nLes maladies neurologiques augmentent-elles le risque ?\nLes facteurs environnementaux jouent-ils un rôle ?\nLe stress peut-il être un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Vasopressins#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on l'épilepsie partielle complexe ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique médical, l'EEG et l'imagerie cérébrale."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'EEG et l'IRM sont essentiels pour visualiser l'activité cérébrale et les anomalies."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier d'un patient à l'autre ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent différer selon la localisation de l'activité épileptique."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier les antécédents de crises et les facteurs déclenchants."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer l'épilepsie partielle complexe chez les enfants ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut se manifester chez les enfants, nécessitant une évaluation spécialisée."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes typiques des crises ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des mouvements involontaires, des hallucinations et des troubles de la conscience."
}
},
{
"@type": "Question",
"name": "Les crises peuvent-elles affecter la mémoire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les crises peuvent entraîner des pertes de mémoire temporaires ou des confusions."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les comportements automatisés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les comportements automatisés incluent des gestes répétitifs sans conscience de l'environnement."
}
},
{
"@type": "Question",
"name": "Les crises peuvent-elles être précédées d'aura ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes ressentent une aura, un signe avant-coureur de la crise."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils persister après la crise ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la fatigue ou la confusion peuvent persister après la crise."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les crises d'épilepsie partielle complexe ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Bien qu'il soit difficile de prévenir, éviter les déclencheurs connus peut aider."
}
},
{
"@type": "Question",
"name": "Quels sont les déclencheurs courants des crises ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress, le manque de sommeil et l'alcool sont des déclencheurs fréquents."
}
},
{
"@type": "Question",
"name": "L'éducation des proches est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer les proches sur les crises et les premiers secours est crucial."
}
},
{
"@type": "Question",
"name": "Les activités physiques sont-elles sûres ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines activités peuvent être sûres, mais il est important de consulter un médecin."
}
},
{
"@type": "Question",
"name": "Comment gérer le stress pour prévenir les crises ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques de relaxation comme la méditation peuvent aider à gérer le stress."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont couramment prescrits ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticonvulsivants comme la carbamazépine et la lamotrigine sont souvent utilisés."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option de traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chirurgie peut être envisagée si les médicaments ne contrôlent pas les crises."
}
},
{
"@type": "Question",
"name": "Quelles sont les alternatives aux médicaments ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les thérapies comportementales et la stimulation cérébrale peuvent être des options."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité du traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par la fréquence des crises et les effets secondaires des médicaments."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie peuvent-ils aider ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain, incluant sommeil et gestion du stress, peut aider."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de l'épilepsie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent les blessures lors des crises et des problèmes psychologiques."
}
},
{
"@type": "Question",
"name": "L'épilepsie peut-elle affecter la vie sociale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des difficultés sociales et des stigmates associés."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de dépression ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes épileptiques présentent un risque plus élevé de dépression et d'anxiété."
}
},
{
"@type": "Question",
"name": "Les crises peuvent-elles entraîner des blessures graves ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les chutes ou les accidents pendant une crise peuvent causer des blessures graves."
}
},
{
"@type": "Question",
"name": "Comment les complications peuvent-elles être gérées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une prise en charge multidisciplinaire est essentielle pour gérer les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de l'épilepsie partielle complexe ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, les traumatismes crâniens et les infections cérébrales sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'épilepsie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'épilepsie peut survenir à tout âge, mais elle est plus fréquente chez les jeunes enfants et les personnes âgées."
}
},
{
"@type": "Question",
"name": "Les maladies neurologiques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la sclérose en plaques peuvent augmenter le risque d'épilepsie."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs comme l'exposition à des toxines peuvent contribuer au risque d'épilepsie."
}
},
{
"@type": "Question",
"name": "Le stress peut-il être un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut déclencher des crises chez certaines personnes épileptiques."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 24/04/2025
Contenu vérifié selon les dernières recommandations médicales
10 publications dans cette catégorie
5 publications dans cette catégorie
Affiliations :
Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province, The Ministry of Education of China, Guangzhou, China.
Publications dans "Épilepsie partielle complexe" :
5 publications dans cette catégorie
Affiliations :
Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province, The Ministry of Education of China, Guangzhou, China.
Publications dans "Épilepsie partielle complexe" :
5 publications dans cette catégorie
Affiliations :
Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province, The Ministry of Education of China, Guangzhou, China.
Publications dans "Épilepsie partielle complexe" :
5 publications dans cette catégorie
Affiliations :
Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province, The Ministry of Education of China, Guangzhou, China.
Publications dans "Épilepsie partielle complexe" :
5 publications dans cette catégorie
Affiliations :
Institute of Neuroscience and Department of Neurology of the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China.
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou 510260, China.
Publications dans "Épilepsie partielle complexe" :
5 publications dans cette catégorie
Affiliations :
Child Neurology and Psychiatry Unit, Systems Medicine Department, Tor Vergata University, Via Montpellier 1, Rome, 00133, Italy.
Publications dans "Épilepsie partielle complexe" :
4 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Affiliated Foshan Maternity and Child Healthcare Hospital, Southern Medical University, Foshan, China.
Publications dans "Épilepsie partielle complexe" :
4 publications dans cette catégorie
Affiliations :
Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province, The Ministry of Education of China, Guangzhou, China.
Publications dans "Épilepsie partielle complexe" :
4 publications dans cette catégorie
Affiliations :
Department of Neurology and Epileptology, The Children's Memorial Health Institute, Al. Dzieci Polskich 20, Warsaw, 04-730, Poland.
Publications dans "Épilepsie partielle complexe" :
4 publications dans cette catégorie
Affiliations :
Department of Development and Regeneration-Section Pediatric Neurology, University Hospitals KU Leuven, Leuven, Belgium.
Publications dans "Épilepsie partielle complexe" :
4 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Medical University Vienna, Vienna, Austria.
Publications dans "Épilepsie partielle complexe" :
4 publications dans cette catégorie
Affiliations :
Department of Pediatric Neurology, Reference Centre for Rare Epilepsies, Necker- Enfants Malades Hospital, University Paris Descartes, Imagine Institute, Paris, France.
Publications dans "Épilepsie partielle complexe" :
4 publications dans cette catégorie
Affiliations :
Diagnose und Behandlungszentrum für Kinder und Jugendliche, Vivantes Klinikum Neuköln, Berlin, Germany.
Publications dans "Épilepsie partielle complexe" :
4 publications dans cette catégorie
Affiliations :
Department of Neurology and Epileptology, The Children's Memorial Health Institute, Al. Dzieci Polskich 20, Warsaw, 04-730, Poland.
Department of Child Neurology, Medical University of Warsaw, Warsaw, Poland.
Publications dans "Épilepsie partielle complexe" :
3 publications dans cette catégorie
Affiliations :
Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province, The Ministry of Education of China, Guangzhou, China.
Publications dans "Épilepsie partielle complexe" :
3 publications dans cette catégorie
Affiliations :
Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province, The Ministry of Education of China, Guangzhou, China.
Publications dans "Épilepsie partielle complexe" :
3 publications dans cette catégorie
Affiliations :
Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province, The Ministry of Education of China, Guangzhou, China.
Publications dans "Épilepsie partielle complexe" :
3 publications dans cette catégorie
Affiliations :
Institute of Neuroscience and Department of Neurology of the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China.
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou 510260, China.
Publications dans "Épilepsie partielle complexe" :
3 publications dans cette catégorie
Affiliations :
Department of pediatrics, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Publications dans "Épilepsie partielle complexe" :
Oxytocin (OT) and vasopressin (VP) are related neuropeptides that regulate many biological processes. In humans, OT and VP act via four G protein-coupled receptors, OTR, V...
The neuropeptide arginine-vasopressin (AVP) is well known for its peripheral effects on blood pressure and antidiuresis. However, AVP also modulates various social and anxiety-related behaviors by its...
In septic shock, vasopressors aim to improve tissue perfusion and prevent persistent organ dysfunction, a characteristic of chronic critical illness (CCI). Adjunctive vasopressin is often used to decr...
We included patients with septic shock receiving vasopressin as a catecholamine adjunct in this retrospective cohort study. We defined vasopressin response as a lowering of the catecholamine dose requ...
In total 938 patients were included; 426 (45.4%) were vasopressin responders. The most frequent trajectory was ED (49.8%), 29.7% developed CCI, and 20.5% had rapid recovery. In survivors to ICU day 14...
Vasopressin responsive status was associated with improved clinical trajectory in septic shock patients. Early vasopressin response is a potential novel prognostic marker for short-term clinical traje...
During hemorrhagic shock, blood loss causes a fall in blood pressure, decreases cardiac output, and, consequently, O...
Randomized controlled trials evaluating the efficacy of vasopressin versus standard of care during cardiopulmonary resuscitation (CPR) have yielded conflicting results. An electronic search of MEDLINE...
The diabetic kidney disease (DKD) is the major cause of the chronic kidney disease (CKD). Enhanced plasma vasopressin (VP) levels have been associated with the pathophysiology of DKD and CKD. Stimulat...
Vasopressin is increasingly used in infants following cardiac surgery. Hyponatremia is a noted adverse event, but incidence and risk factors remain undefined....
The primary objective was to identify the incidence of vasopressin-induced hyponatremia. Secondary objectives included comparing baseline and change in serum sodium concentrations between infants rece...
This Institutional Review Board-approved, retrospective case-control study included infants <6 months following cardiac surgery receiving vasopressin for ≥6 hours at a tertiary care, academic hospital...
Of the included 142 infants, 20 (14.1%) developed hyponatremia and were matched with 40 controls. There was significant difference in median nadir between controls and cases, 142.0 versus 128.5 mEq/L ...
Vasopressin-induced hyponatremia incidence was <15%. Vasopressin duration was independently associated with hyponatremia development....
To describe the acute hemodynamic effect of vasopressin on the Fontan circulation, including systemic and pulmonary pressures and resistances, left atrial pressure, and cardiac index....
Prospective, open-label, nonrandomized study (NCT04463394)....
Cardiac catheterization laboratory at Lucile Packard Children's Hospital, Stanford....
Patients 3-50 years old with a Fontan circulation who were referred to the cardiac catheterization laboratory for hemodynamic assessment and/or intervention....
A 0.03 U/kg IV (maximum dose 1 unit) bolus of vasopressin was administered over 5 minutes, followed by a maintenance infusion of 0.3 mU/kg/min (maximum dose 0.03 U/min)....
Comprehensive cardiac catheterization measurements before and after vasopressin administration. Measurements included pulmonary artery, atrial, and systemic arterial pressures, oxygen saturations, and...
In Fontan patients undergoing cardiac catheterization, vasopressin administration resulted in a significant increase in systolic blood pressure, SVR, and left atrial pressure, decrease in PVR, and no ...
Vasoplegia, or vasoplegic shock, is a syndrome whose main characteristic is reducing blood pressure in the presence of a standard or high cardiac output. For the treatment, vasopressors are recommende...
This is a systematic review of the literature with meta-analysis, written according to the recommendations of the PRISMA report. The SCOPUS, PubMed, and ScienceDirect databases were used to select the...
In total, 2,090 articles were retrieved; after applying the inclusion and exclusion criteria, ten studies were selected to compose the present review. We found no significant difference when assessing...
Considering the outcomes included in our study, it is worth noting that most studies showed that using vasopressin was safe and can be considered in managing postoperative vasoplegic shock....
The use of arginine vasopressin (AVP) and terlipressin to treat hypotension in preterm neonates is increasing. Our aim was to review the available evidence on the efficacy and safety of AVP and terlip...
MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, Web of Science, and Google Scholar from inception to September 2021 were searched for studies of AVP and terlipressin in the treatm...
Fifteen studies describing the use of AVP (n = 12) or terlipressin (n = 3) among 148 preterm neonates were included. Certainly, the available evidence for the primary outcome of end-organ perfusion ra...
AVP and terlipressin may improve measured blood pressure values and possibly end-organ perfusion among neonates with refractory hypotension. However, the efficacy-safety balance of these drugs should ...